Iterum Therapeutics plc
ITRMDelisted Jun 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659323
Iterum Therapeutics plc was delisted on Jun 23, 2026; its insiders filed their last Form 4 on Nov 20, 2025; 18 institutions reported holding it in 13F filings for Q1 2026, worth $41.3K in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Iterum Therapeutics plc changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 23 | 17 | −6 |
| Shares | 290.0K | 186.8K | −103.2K (−35.6%) |
| Value | $243.7K | $187.3K | −$56.4K (−23.1%) |
New holders (1)
Institutions that held Iterum Therapeutics plc at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Northwestern Mutual Wealth Management Co | 133 | $133 | 0.00% |
Sold out (7)
Institutions that held Iterum Therapeutics plc at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Dimensional Fund Advisors LP | 58,497 | $49.0K |
| Virtu Financial LLC | 23,223 | $20.0K |
| Franklin Resources Inc | 17,427 | $14.6K |
| The PNC Financial Services Group, Inc. | 445 | $374 |
| Creative Financial Designs Inc | 200 | $168 |
| Advisory Services Network, LLC | 78 | $66 |
| IFP Advisors, Inc | 399 | – |